Publication | Open Access

Clinicopathological Features Among Patients With Advanced Human Epidermal Growth Factor–2-Positive Breast Cancer With Prolonged Clinical Benefit to First-Line Trastuzumab-Based Therapy: A Retrospective Cohort Study

Prolonged Clinical BenefitRetrospective Cohort StudyBreast OncologyMedicinePathologyBreast CancerFirst-line Trastuzumab-based TherapyDermatologyCancer TreatmentOncologyRadiation Oncology